NEW YORK (GenomeWeb News) – The Fox Chase Cancer Center in Philadelphia has launched the Institute for Personalized Medicine, which will use the center's sample repository and oncology programs along with sequencing to develop personalized chemotherapy approaches.

The IPM will use the center's biosample repository and tumor bank to develop genetic information about individual tumors, and it will incorporate this type of data in its Phase I Clinical Trials Program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.

In Science this week: the Human Silencing Hub protein complex, and more.